Your browser doesn't support javascript.
loading
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population.
Wilson, Timothy R; Yu, Jianjun; Lu, Xuyang; Spoerke, Jill M; Xiao, Yuanyuan; O'Brien, Carol; Savage, Heidi M; Huw, Ling-Yuh; Zou, Wei; Koeppen, Hartmut; Forrest, William F; Fridlyand, Jane; Fu, Ling; Tam, Rachel; Schleifman, Erica B; Sumiyoshi, Teiko; Molinero, Luciana; Hampton, Garret M; O'Shaughnessy, Joyce A; Lackner, Mark R.
Afiliação
  • Wilson TR; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Yu J; Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.
  • Lu X; Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.
  • Spoerke JM; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Xiao Y; Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.
  • O'Brien C; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Savage HM; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Huw LY; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Zou W; Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.
  • Koeppen H; Department of Research Pathology, Genentech Inc., South San Francisco, CA, USA.
  • Forrest WF; Department of Bioinformatics, Genentech Inc., South San Francisco, CA, USA.
  • Fridlyand J; Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA.
  • Fu L; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Tam R; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Schleifman EB; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Sumiyoshi T; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Molinero L; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • Hampton GM; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA.
  • O'Shaughnessy JA; US Oncology, Dallas, TX, USA.
  • Lackner MR; Baylor Sammons Cancer Center, Dallas, TX, USA.
NPJ Breast Cancer ; 2: 16022, 2016.
Article em En | MEDLINE | ID: mdl-28721382

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article